A treatment menu uses the word peptide. The name of the medicine is still missing.
A peptide name tells only part of the story
Picture beads joined in a row. In a peptide, the “beads” are the tiny building blocks also found in proteins. The row is short. Insulin is a peptide too.
That word alone does not tell you what is in an offer. Ask the person assessing your health to name the medicine and explain why they are considering it for you.
US rules treat medicines differently depending on how they are made and offered (as of September 2026). Below are the differences between an approved medicine, medicine made to order and a product labelled for research.
A finished medicine with approval
The agency reviewing US medicines is FDA—the Food and Drug Administration.
Peptide care offers may name semaglutide or tirzepatide. These medicines copy a body message called a hormone. That hormone affects hunger and the amount of sugar in blood.
Semaglutide is the medicine name; Ozempic and Wegovy are brands containing it. As of September 2026, approved uses include treating type 2 diabetes with Ozempic and managing weight with Wegovy.
The brands Mounjaro and Zepbound contain tirzepatide. Mounjaro has FDA approval for uses including type 2 diabetes treatment; Zepbound has approval for uses including weight management (September 2026).
Look at the exact product: FDA approval goes with that medicine and the uses in its official label. Other peptide products do not gain approval just by sharing that word.
Ask the person offering treatment to show you the label for your exact medicine and point out which condition it is approved to treat.
Medicine made to order
Compounding is a way for a pharmacist or doctor to prepare a medicine rather than supply a ready-made drug product.
US law allows compounding when the maker follows the rules that apply to that medicine (September 2026). It can address a patient’s need that a ready-made product leaves unmet.
For an ordinary pharmacy, the rules include making it for a named patient with a prescription; other conditions also apply (September 2026).
Ask who will make your medicine, which rules they follow and why a ready-made approved medicine would not meet your need.
With compounding, the finished medicine lacks FDA approval. The medicine reaches sale without FDA reviewing its safety, how well it works or how it is made (September 2026).
The agency sets out that distinction in its compounding questions and answers.
A bottle labelled for research is a reason to pause
Some bottles or sales pages say “not for human consumption.” That means people are not meant to use the contents. Others say “for research purposes.” These are product labels, not an invitation to a medical study.
FDA’s warning concerns these weight-loss products offered to people (September 2026). With their quality unknown, using them could harm your health.
See the agency’s advice on unapproved weight-loss drugs.
You can see how to place an order. You cannot see how to get a question answered later.
Ask what happens after the visit
For this conversation, think of monitoring as a plan for checking back. Ask what will be reviewed and how to contact the person caring for you. What happens if the plan changes?
With telehealth, the conversation happens remotely—for example, in an online visit. An in-person clinic is another place to discuss care. For either route, request the name of the person who will assess you.
National guidance says a doctor must arrange any test or examination needed to assess your health, or refer you to someone else for that care.
Doctors get their licences from state medical boards. These bodies keep public records and can discipline a doctor—take action for breaking the rules.
The Federation of State Medical Boards gives state boards this advice to consider. It is advice rather than law; the rules that bind doctors come from each state (September 2026).
Before agreeing
What health history do you need from me? What else could address my concern? How will we decide whether this plan fits?
Between visits
Who reads my messages? How soon can I expect an answer? What if I need an examination in person?
At the next review
What will we talk about? What would make us change course? What are the options if I want to stop?
My concern
and my history
The options
and the questions
The next contact
and a fresh review
A service has a polished page. Now you want a name and a record you can check.
Look up the doctor and the pharmacy separately
The licence records a state’s permission for a doctor to practise.
For an online appointment, the doctor’s permission to practise must cover your location under state rules (as of September 2026).
Your state here means the place you are in during the visit.
Licensing advice from the US Department of Health and Human Services follows this location rule.
Find the licence behind the name
Ask for the spelling
Request the doctor’s full name and the state where they say they can treat you.
Find the state board
The directory gathers the state medical boards’ own sites, so you can open the board for your location.
Find the board for your stateRead the public record
Check that the licence is active. Read any action the board has taken against the doctor. A clear record does not rate a doctor’s skill.
Request the name of the pharmacy making or sending the medicine. Look for that business in your state pharmacy board’s records.
FDA’s state pharmacy lookup page points to those records.
If the person assessing you is a nurse practitioner or physician assistant rather than a doctor, ask which state body licenses them and how to check its records.
A monthly fee looks manageable. It is still unclear what that fee includes.
Read the bill as parts, then ask for the total
A September 2026 check of a small set of online weight-care pages found membership charges often left medicine out.
Request a written breakdown. Use the same set of questions for an online service or an in-person clinic.
- The care
- Does the fee cover the first visit, later reviews and messages?
- The medicine
- What is the price for the named product? What period does it cover?
- Tests and extras
- Are tests, supplies or delivery included? What is charged separately?
- The commitment
- What changes after an opening offer? How do cancellation and refunds work?
A maker’s published list price can differ from a cash deal or the amount an insured person pays for a weight-loss medicine (September 2026).
The insurer needs the medicine name
For coverage, give the insurer the drug name and the condition being treated. Ask whether approval in advance is needed and what your share of the bill would be.
An offer sounds reassuring, but the explanation leaves something out.
Give these claims a second thought
Open a claim to read the distinction behind it.
Myth“FDA registered” means the medicine has approval.
A business may describe itself as “FDA registered” because it has filed its details with the agency. Filing those details gives no approval to the business or the medicines it makes (federal rule, September 2026).
The federal rule on FDA records also says putting a drug on file does not give it approval.
Ask: “Does this exact medicine have FDA approval, and for which use?”
MythAn online form always rules out real care.
National guidance allows some online visits to happen through written questions and answers. The doctor must still gather enough information to assess and treat you properly.
A fixed form alone is not enough under that guidance. The doctor needs a way to ask more questions and learn more about your health.
State rules on online prescribing differ, as of September 2026.
The national advice on online doctor visits sets out that distinction. State boards can consider this advice when writing their own rules.
Ask how the doctor will follow up on your answers and whether that kind of visit is allowed where you are.
MythA lower fee makes the rest of the checks optional.
FDA warns about very low prices, but price by itself cannot tell you whether a pharmacy is safe. Check the other signs too: does it require a prescription, hold a licence and have a pharmacist you can speak to?
Its online pharmacy checklist covers the checks together.
For a problem after treatment
Keep the label and medicine name with the contact details for whoever is treating you. Ask in advance how to report a problem and how to get help between visits.
MedlinePlus advises emergency care for severe allergic-reaction symptoms, which can include a swollen tongue or difficulty breathing (checked September 2026).
The MedlinePlus page on severe allergic reactions is published through the US National Library of Medicine.
Patients can also send a report about a medicine problem through MedWatch, FDA’s public reporting service.
You are ready for a conversation, even if you are not ready for treatment.
Keep these questions beside you
- Which person assesses me, and how do I find their licence record?
- What is the exact medicine, and why discuss it for my concern?
- What other choices do I have, including no medicine?
- Who makes my medicine? Does it have FDA approval? Name the pharmacy sending it to me. How do I look up its licence?
- What will follow-up involve, and who answers between visits?
- How much will I pay once a short-term offer ends?
An unclear answer is still a useful answer. Write down what is missing and take that question back to the person offering care.
Keep the text copy